Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2019 Jan 10;1(1):CD012405.
doi: 10.1002/14651858.CD012405.pub2.

Deep brain stimulation for dystonia

Filipe B Rodrigues  1 , Gonçalo S Duarte, David Prescott, Joaquim Ferreira, João Costa
Affiliations
Meta-Analysis

Deep brain stimulation for dystonia

Filipe B Rodrigues et al. Cochrane Database Syst Rev. .

Abstract

Background: Dystonia is a painful and disabling disorder, characterised by painful, involuntary posturing of the affected body region(s). Deep brain stimulation is an intervention typically reserved for severe and drug-refractory cases, although uncertainty exists regarding its efficacy, safety, and tolerability.

Objectives: To compare the efficacy, safety, and tolerability of deep brain stimulation (DBS) versus placebo, sham intervention, or best medical care, including botulinum toxin and resective or lesional surgery, in adults with dystonia.

Search methods: We identified studies by searching the CENTRAL, MEDLINE, Embase, three other databases, four clinical trial registries, four grey literature databases, and reference lists of included articles. We ran the last search of all elements of the search strategy, with no language restrictions, on 29 May 2018.

Selection criteria: Double-blind, parallel, randomised, controlled trials (RCTs) comparing DBS with sham stimulation, best medical care, or placebo in adults with dystonia.

Data collection and analysis: Two independent review authors assessed records, selected included studies, extracted data onto a standardised (or prespecified) data extraction form, and evaluated the risk of bias. We resolved disagreements by consensus or by consulting a third review author. We conducted meta-analyses using a random-effects model, to estimate pooled effects and corresponding 95% confidence intervals (95% CI). We assessed the quality of the evidence with GRADE methods. The primary efficacy outcome was symptom improvement on any validated symptomatic rating scale, and the primary safety outcome was adverse events.

Main results: We included two RCTs, enrolling a total of 102 participants. Both trials evaluated the effect of DBS on the internal globus pallidus nucleus, and assessed outcomes after three and six months of stimulation. One of the studies included participants with generalised and segmental dystonia; the other included participants with focal (cervical) dystonia. We assessed both studies at high risk for performance and for-profit bias. One study was retrospectively registered with a clinical trial register, we judged the second at high risk of detection bias.Low-quality evidence suggests that DBS of the internal globus pallidus nucleus may improve overall cervical dystonia-related symptoms (mean difference (MD) 9.8 units, 95% CI 3.52 to 16.08 units; 1 RCT, 59 participants), cervical dystonia-related functional capacity (MD 3.8 units, 95% CI 1.41 to 6.19; 1 RCT, 61 participants), and mood at three months (MD 3.1 units, 95% CI 0.73 to 5.47; 1 RCT, 61 participants).Low-quality evidence suggests that In people with cervical dystonia, DBS may slightly improve the overall clinical status (MD 2.3 units, 95% CI 1.15 to 3.45; 1 RCT, 61 participants). We are uncertain whether DBS improves quality of life in cervical dystonia (MD 3 units, 95% CI -7.71 to 13.71; 1 RCT, 57 participants; very low-quality evidence), or emotional state (MD 2.4 units, 95% CI -6.2 to 11.00; 1 RCT, 56 participants; very low-quality evidence).Low-quality evidence suggests that DBS of the internal globus pallidus nucleus may improve generalised or segmental dystonia-related symptoms (MD 14.4 units, 95% CI 8.0 to 20.8; 1 RCT, 40 participants), overall clinical status (MD 3.5 units, 95% CI 2.33 to 4.67; 1 RCT, 37 participants), physical functioning-related quality of life (MD 6.3 units, 95% CI 1.06 to 11.54; 1 RCT, 33 participants), and overall dystonia-related functional capacity at three months (MD 3.1 units, 95% CI 1.71 to 4.48; 1 RCT, 39 participants). We are uncertain whether DBS improves physical functioning-related quality of life (MD 5.0 units, 95% CI -2.14 to 12.14, 1 RCT, 33 participants; very low-quality evidence), or mental health-related quality of life (MD -4.6 units, 95% CI -11.26 to 2.06; 1 RCT, 30 participants; very low-quality evidence) in generalised or segmental dystonia.We pooled outcomes related to safety and tolerability, since both trials used the same intervention and comparison. We found very low-quality evidence of inconclusive results for risk of adverse events (relative risk (RR) 1.58, 95% 0.98 to 2.54; 2 RCTs, 102 participants), and tolerability (RR 1.86, 95% CI 0.16 to 21.57; 2 RCTs,102 participants).

Authors' conclusions: DBS of the internal globus pallidus nucleus may reduce symptom severity and improve functional capacity in adults with cervical, segmental or generalised moderate to severe dystonia (low-quality evidence), and may improve quality of life in adults with generalised or segmental dystonia (low-quality evidence). We are uncertain whether the procedure improves quality of life in cervical dystonia (very low-quality evidence). We are also uncertain about the safety and tolerability of the procedure in adults with either cervical and generalised, or segmental dystonia (very-low quality evidence).We could draw no conclusions for other populations with dystonia (i.e. children and adolescents, and adults with other types of dystonia), or for other DBS protocols (i.e. other target nuclei or stimulation paradigms). Further research is needed to establish the long-term efficacy and safety of DBS of the internal globus pallidus nucleus.

PubMed Disclaimer

Conflict of interest statement

Gonçalo S Duarte: none known.

Filipe B Rodrigues: none known.

David Prescott: none known.

Joaquim J Ferreira: has held consultancy functions with GlaxoSmithKline, Novartis, TEVA, Lundbeck, Solvay, Abbott, BIAL, Merck‐Serono, Merz, and Ipsen, and has received grants from GlaxoSmithKline, Grunenthal, Fundação MSD (Portugal), and TEVA.

João Costa: His PhD was on DBS.

Figures

1
1
Study flow diagram
2
2
Risk of bias graph: review authors' judgements about each source of risk of bias presented as percentages across all included studies
3
3
Risk of bias summary: review authors' judgements about each source of risk of bias for each included study
4
4
Forest plot of comparison: Neurostimulation vs sham stimulation for outcome – adverse events
1.1
1.1. Analysis
Comparison 1: Neurostimulation vs sham stimulation, Outcome 1: Adverse events
See this image and copyright information in PMC

Update of

  • doi: 10.1002/14651858.CD012405

References

References to studies included in this review

Kupsch 2006 {published data only}
    1. Kupsch A, Benecke R, Müller J, Trottenberg T, Schneider GH, Poewe W, et al. Pallidal deep-brain stimulation in primary generalized or segmental dystonia. The New England Journal of Medicine 2006;355(19):1978. [CLINICALTRIALS.GOV: NCT00142259] [DOI: 10.1056/NEJMoa063618] - DOI - PubMed
Volkmann 2014 {published data only}
    1. Volkmann J, Mueller J, Deuschl G, Kuhn AA, Krauss JK, Poewe W, et al, the DBS study group for dystonia. Pallidal neurostimulation in patients with medication-refractory cervical dystonia: a randomised, sham-controlled trial. Lancet Neurology 2014;13(9):875-84. [CLINICALTRIALS.GOV: NCT00148889] [DOI: 10.1016/S1474-4422(14)70143-7] - DOI - PubMed

References to studies excluded from this review

Dinkelbach 2015 {published data only}
    1. Dinkelbach L, Mueller J, Poewe W, Delazer M, Elben S, Wolters, A et al. Cognitive outcome of pallidal deep brain stimulation for primary cervical dystonia: one year follow-up results of a prospective multicenter trial. Parkinsonism & Related Disorders 2015;21(8):976-80. [DOI: 10.1016/j.parkreldis.2015.06.002] - DOI - PubMed
Ellis 2011 {published data only}
    1. Ellis TL. Dystonia and the role of deep brain stimulation. ISRN Surgery 2011;2011:193718. [DOI: 10.5402/2011/193718] - DOI - PMC - PubMed
Foncke 2005 {published data only}
    1. Foncke EMJ Speelman JD. Primary generalized dystonia and deep brain stimulation: a randomized, placebo-controlled, double-blind, multicentre study. Nederlands Tijdschrift voor Geneeskunde 2005;149(20):1123-4. - PubMed
Gale 2011 {published data only}
    1. Gale JT, Martinez-Rubio C, Sheth SA, Eskandar EN. Intra-operative behavioral tasks in awake humans undergoing deep brain stimulation surgery. Journal of Visualized Experiments 2011;47:2156. [DOI: 10.3791/2156] - DOI - PMC - PubMed
Grabli 2009 {published data only}
    1. Grabli D, Ewenczyk C, Coelho-Braga MC, Lagrange C, Fraix V, Cornu P, et al. Interruption of deep brain stimulation of the globus pallidus in primary generalized dystonia. Movement Disorders 2009;24(16):2363-9. [DOI: 10.1002/mds.22827] - DOI - PubMed
Houeto 2007 {published data only}
    1. Houeto JL, Yelnik J, Bardinet E, Vercueil L, Krystkowiak P, Mesnage V, et al. Acute deep-brain stimulation of the internal and external globus pallidus in primary dystonia: functional mapping of the pallidum. Archives of Neurology 2007;64(9):1281-6. [DOI: 10.1001/archneur.64.9.1281] - DOI - PubMed
Kefalopoulou 2009 {published data only}
    1. Kefalopoulou Z, Paschali A, Markaki E, Vassilakos P, Ellul J, Constantoyannis C. A double-blind study on a patient with tardive dyskinesia treated with pallidal deep brain stimulation. Acta Neurologica Scandinavica 2009;119(4):269-73. [DOI: 10.1111/j.1600-0404.2008.01115.x] - DOI - PubMed
Kiss 2007 {published data only}
    1. Kiss ZH, Doig-Beyaert K, Eliasziw M, Tsui J, Haffenden A, Suchowersky O, Stereotactic Section of the Canadian Neurosurgical Society, Canadian Movement Disorders Group. The Canadian multicentre study of deep brain stimulation for cervical dystonia. Brain 2007;130(Pt 11):2879-86. - PubMed
Koch 2014 {published data only}
    1. Koch G, Porcacchia P, Ponzo V, Carrillo F, Cáceres-Redondo MT, Brusa L, et al. Effects of two weeks of cerebellar theta burst stimulation in cervical dystonia patients. Brain Stimulation 2014;7(4):564-72. [DOI: 10.1016/j.brs.2014.05.002] - DOI - PubMed
Kovacs 2013 {published data only}
    1. Kovacs N, Deli G, Bosnyak E, Balas I, Komoly S, Janszky J. Comparison of double monopolar and interleaving stimulation modes in the treatment of primary generalized and segmental dystonia. Movement Disorders 2013;28:S430. [DOI: 10.1002/mds.25605] - DOI
Levin 2014 {published data only}
    1. Levin J, Singh A, Feddersen B, Mehrkens JH, Botzel K. Onset latency of segmental dystonia after deep brain stimulation cessation: a randomized, double-blind crossover trial. Movement Disorders 2014;29(7):944-9. [DOI: 10.1002/mds.25780] - DOI - PubMed
Mills 2011 {published data only}
    1. Mills KA, Scherzer R, Collins L, Starr PA, Jill OL. Weight change following pallidal or subthalamic nucleus deep brain stimulation in Parkinson's disease and dystonia. Movement Disorders 2011;26:S75-6. [DOI: 10.1002/mds.23764] - DOI
Morgan 2008 {published data only}
    1. Morgan JC, Sethi KD. A single-blind trial of bilateral globus pallidus internus deep brain stimulation in medically refractory cervical dystonia. Current Neurology & Neuroscience Reports 2008;8(4):279-80. - PubMed
Moro 2009 {published data only}
    1. Moro E, Piboolnurak P, Arenovich T, Hung SW, Poon YY, Lozano AM. Pallidal stimulation in cervical dystonia: Clinical implications of acute changes in stimulation parameters. European Journal of Neurology 2009;16(4):506-12. [DOI: 10.1111/j.1468-1331.2008.02520.x] - DOI - PubMed
Moro 2012 {published data only}
    1. Moro E, Pascual-Sedano BM, Shah B, Poon YY, Fallis M, Lozano AM, et al. Cervical dystonia improves with high frequency but not with low frequency pallidal stimulation. Movement Disorders 2012;27:S319-20. [DOI: 10.1002/mds.25051] - DOI
Mueller 2008 {published data only}
    1. Mueller J, Skogseid IM, Benecke R, Kupsch A, Trottenberg T, Poewe W, et al. Pallidal deep brain stimulation improves quality of life in segmental and generalized dystonia: results from a prospective, randomized sham-controlled trial. Movement Disorders 2008;23(1):131-4. [DOI: 10.1002/mds.21783] - DOI - PubMed
Odekerken 2012 {published data only}
    1. Odekerken VJ, Van Laar T, Mosch A, Van Vugt J, Nijssen PC, Schmand BA, et al. Randomized multicenter trial comparing bilateral subthalamic nucleus DBS and bilateral globus pallidus internus DBS for advanced Parkinson's disease (NSTAPS). Movement Disorders 2012;27:S165. [DOI: 10.1002/mds.25051] - DOI
Odekerken 2013 {published data only}
    1. Odekerken VJ, Laar T, Staal MJ, Mosch A, Hoffmann CF, Nijssen PC, et al. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial. Lancet Neurology 2013;12(1):37-44. [DOI: 10.1016/s1474-4422(12)70264-8] - DOI - PubMed
Ostrem 2011 {published data only}
    1. Ostrem JL, Racine CA, Glass GA, Grace JK, Volz MM, Heath SL, et al. Subthalamic nucleus deep brain stimulation in primary cervical dystonia. Neurology 2011;76(10):870-8. [DOI: 10.1212/WNL.0b013e31820f2e4f] - DOI - PubMed
Pauls 2011 {published data only}
    1. Pauls KAM, Hammesfahr S, Moro E, Moore AP, Binder E, El Majdoub, et al. Thalamic and subthalamic deep brain stimulation for idiopathic dystonia with head tremor. Movement Disorders 2011;26:S225-6. [DOI: 10.1002/mds.23764] - DOI - PubMed
Pretto 2008 {published data only}
    1. Pretto TE, Dalvi A, Kang UJ, Penn RD. A prospective blinded evaluation of deep brain stimulation for the treatment of secondary dystonia and primary torticollis syndromes. Journal of Neurosurgery 2008;109(3):405-9. [DOI: 10.3171/JNS/2008/109/9/0405] - DOI - PubMed
Schjerling 2011 {published data only}
    1. Schjerling L, Hjermind L, Jespersen B, Madsen FF, Brennum J, Jensen SR, et al. A double-blind crossover trial of DBS in GPI and STN in dystonia. Acta Neurochirurgica 2011;153(3):702. [DOI: 10.1007/s00701-010-0919-8] - DOI
Schjerling 2013 {published data only}
    1. Schjerling L, Hjermind LE, Jespersen B, Madsen FF, Brennum J, Jensen SR, et al. A randomized double-blind crossover trial comparing subthalamic and pallidal deep brain stimulation for dystonia: clinical article. Journal of Neurosurgery 2013;119(6):1537-45. [DOI: 10.3171/2013.8.JNS13844] - DOI - PubMed
Schupbach 2012 {published data only}
    1. Schupbach MWM, You H, Isaias IU, Loennfors-Weitzel T, Vingerhoets F, Krauss JK, et al. Long-term follow-up in patients with deep brain stimulation for cervical dystonia. Movement Disorders 2012;27:S322-3. [DOI: 10.1002/mds.25051] - DOI
Simms 2011 {published data only}
    1. Simms HN, Sandhu M, Honey CR. Is bilateral pallidal deep brain stimulation necessary in cervical dystonia? Acta Neurochirurgica 2011;153(3):670-1. [DOI: 10.1007/s00701-010-0919-8] - DOI
Skogseid 2009 {published data only}
    1. Skogseid IM, Ramm-Pettersen J, Kerty E, Dietrichs E, Volkmann J, Roste GK. Good long-term efficacy of pallidal DBS for primary cervical and generalized dystonia: a prospective, single-blinded, single centre study. European Journal of Neurology 2009;16(Suppl 3):190. [DOI: 10.1111/j.1468-1331.2009.02821.x] - DOI
Slotty 2015 {published data only}
    1. Slotty PJ, Poologaindran A, Honey CR. A prospective, randomized, blinded assessment of multitarget thalamic and pallidal deep brain stimulation in a case of hemidystonia. Clinical Neurology and Neurosurgery 2015;138:16-9. [DOI: 10.1016/j.clineuro.2015.07.012] - DOI - PubMed
Teixeira 2015 {published data only}
    1. Teixeira MJ, Cury RG, Galhardoni R, Barboza VR, Alho E, Seixas CM, et al. Deep brain stimulation of the dentate nucleus improves cerebellar ataxia: a double-blind N = 1 study. Movement Disorders 2015;30:S368. [DOI: 10.1002/mds.26295] - DOI
Vidailhet 2005 {published data only}
    1. Vidailhet M, Vercueil L, Houeto JL, Krystkowiak P, Benabid AL, Cornu P, et al. Bilateral deep-brain stimulation of the globus pallidus in primary generalized dystonia. New England Journal of Medicine 2005;352(5):459-67. [DOI: 10.1056/NEJMoa042187] - DOI - PubMed
Volkmann 2012 {published data only}
    1. Volkmann J, Wolters A, Kupsch A, Muller J, Kuhn AA, Schneider GH, et al, the DBS study group for dystonia. Pallidal deep brain stimulation in patients with primary generalised or segmental dystonia: 5-year follow-up of a randomised trial. Lancet Neurology 2012;11(12):1029-38. [DOI: 10.1016/S1474-4422(12)70257-0] - DOI - PubMed
Weaver 2009 {published data only}
    1. Weaver FM, Follett K, Stern M, Hur K, Harris C, Marks WJ Jr, et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA 2009;301(1):63-73. [DOI: 10.1001/jama.2008.929] - DOI - PMC - PubMed
Wojtecki 2015 {published data only}
    1. Wojtecki L, Groiss SJ, Ferrea S, Elben S, Hartmann CJ, Dunnett SB, et al. A prospective pilot trial for pallidal deep brain stimulation in Huntington's disease. Frontiers in Neurology 2015;6:177. [DOI: 10.3389/fneur.2015.00177] - DOI - PMC - PubMed

References to ongoing studies

Drechsel 2017 {published data only}
    1. Drechsel H, Malzahn U, Roeser C, Heuschmann P, Volkmann J. Design of a randomized, sham-controlled trial of pallidal neurostimulation versus botulinum toxin treatment for cervical dystonia (StimTox-CD). In: Movement Disorders. 2017. - PMC - PubMed

Additional references

Abrams 2005
    1. Abrams KR, Gillies CL, Lambert PC. Meta-analysis of heterogeneously reported trials assessing change from baseline. Statistics in Medicine 2005;24(24):3823-44. - PubMed
Albanese 2013
    1. Albanese A, Bhatia K, Bressman SB, Delong MR, Fahn S, Fung VS, et al. Phenomenology and classification of dystonia: a consensus update. Movement Disorders 2013;28(7):863-73. - PMC - PubMed
Altman 2002
    1. Altman DG, Deeks JJ. Meta-analysis, Simpson's paradox, and the number needed to treat. BMC Medical Research Methodology 2002;2:3. - PMC - PubMed
Atkins 2004
    1. Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al. Grading quality of evidence and strength of recommendations. BMJ 2004;328(7454):1490. - PMC - PubMed
Balint 2015
    1. Balint B, Bhatia KP. Isolated and combined dystonia syndromes - an update on new genes and their phenotypes. European Journal of Neurology 2015;22(4):610-7. - PubMed
Balshem 2011
    1. Balshem H, Helfand M, Schünemann HJ, Oxman AD, Kunz R, Brozek J, et al. GRADE guidelines: 3. Rating the quality of evidence. Journal of Clinical Epidemiology 2011;64(4):401-6. - PubMed
Becerra 2016
    1. Becerra JE, Zorro O, Ruiz-Gaviria R, Castañeda-Cardona C, Otálora-Esteban M, Henao S, et al. Economic analysis of deep brain stimulation in Parkinson's disease: systematic review of the literature. World Neurosurgery 2016;93:44-9. - PubMed
Brożek 2006
    1. Brożek JL, Guyatt GH, Schünemann HJ. How a well-grounded minimal important difference can enhance transparency of labelling claims and improve interpretation of a patient reported outcome measure. Health and Quality of Life Outcomes 2006;4:69. - PMC - PubMed
Burke 1985
    1. Burke RE, Fahn S, Marsden CD, Bressman SB, Moskowitz C, Friedman J. Validity and reliability of a rating scale for the primary torsion dystonias. Neurology 1985;35:73-7. - PubMed
Calne 1988
    1. Calne DB, Lang AE. Secondary dystonia. Advances in Neurology 1988;50:9-33. - PubMed
Carpenter 2013
    1. Carpenter JR, Kenward MG. Multiple Imputation and its Application. Wiley, 2013.
Castelão 2017
    1. Castelão M, Marques RE, Duarte GS, Rodrigues FB, Ferreira J, Sampaio C, et al. Botulinum toxin type A therapy for cervical dystonia. Cochrane Database of Systematic Reviews 2017, Issue 12. Art. No: CD003633. [DOI: 10.1002/14651858.CD003633.pub3] - DOI - PMC - PubMed
Chen 2014
    1. Chen YF, Hemming K, Chilton P, Gupta K, Altman D, Lilford R. Scientific hypotheses can be tested by comparing the effects of one treatment over many diseases in a systematic review. Journal of Clinical Epidemiology 2014;67:1309-19. - PubMed
Chiken 2014
    1. Chiken S, Nambu A. Disrupting neuronal transmission: mechanism of DBS? Frontiers in Systems Neuroscience 2014;8:33. - PMC - PubMed
Chiken 2015
    1. Chiken S, Nambu A. Mechanism of deep brain stimulation: inhibition, excitation, or disruption? Neuroscientist 2015;22(3):313-22. - PMC - PubMed
Comella 2015
    1. Comella CL, Fox SH, Bhatia KP, Perlmutter JS, Jinnah HA, Zurowski M, et al. Development of the comprehensive Cervical Dystonia Rating Scale: methodology. Movement Disorders 2015;2(2):135-41. - PMC - PubMed
Comella 2016
    1. Comella CL, Perlmutter JS, Jinnah HA, Waliczek TA, Rosen AR, Galpern WR, et al. Clinimetric testing of the comprehensive cervical dystonia rating scale. Movement Disorders 2016;31(4):563-9. [DOI: 10.1002/mds.26534] - DOI - PMC - PubMed
Consky 1990
    1. Consky ES, Basinki A, Belle L, Ranawaya R, Lang AE. The Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS): assessment of validity and inter-rater reliability. Neurology 1990;40:445.
Costa 2004
    1. Costa J, Espírito-Santo CC, Borges AA, Ferreira J, Coelho MM, Moore P, et al. Botulinum toxin type A therapy for blepharospasm. Cochrane Database of Systematic Reviews 2004, Issue 2. Art. No: CD004900. [DOI: 10.1002/14651858.CD004900.pub2] - DOI - PubMed
Covidence [Computer program]
    1. Veritas Health Innovation Covidence. Version accessed June 2018. Melbourne, Australia: Veritas Health Innovation, 2015. Available at www.covidence.org.
Duarte 2016
    1. Duarte GS, Castelão M, Rodrigues FB, Marques RE, Ferreira J, Sampaio C, et al. Botulinum toxin type A versus botulinum toxin type B for cervical dystonia. Cochrane Database of Systematic Reviews 2016, Issue 10. Art. No: CD004314. [DOI: 10.1002/14651858.CD004314.pub3] - DOI - PMC - PubMed
Duarte 2018
    1. Duarte GD, Rodrigues FB, Ferreira JJ, Costa J. Adverse events with botulinum toxin treatment in cervical dystonia: How much should we blame placebo? Parkinsonism & Related Disorders 2018 Jun 14 [Epub ahead of print];S1353-8020(18):30276-1. [DOI: 10.1016/j.parkreldis.2018.06.017] - DOI - PubMed
Eggington 2014
    1. Eggington S, Valldeoriola F, Chaudhuri KR, Ashkan K, Annoni E, Deuschl G. The cost-effectiveness of deep brain stimulation in combination with best medical therapy, versus best medical therapy alone, in advanced Parkinson's disease. Journal of Neurology 2014;261:106-16. - PMC - PubMed
Fasano 2012
    1. Fasano A, Daniele A, Albanese A. Treatment of motor and non-motor features of Parkinson's disease with deep brain stimulation. Lancet Neurology 2012;11(5):429-42. - PubMed
Filali 2004
    1. Filali M, Hutchison WD, Palter VN, Lozano AM, Dostrovsky JO. Stimulation-induced inhibition of neuronal firing in human subthalamic nucleus. Experimental Brain Research 2004;156(3):274-81. - PubMed
Flora 2010
    1. Flora ED, Perera CL, Cameron AL, Maddern GJ. Deep brain stimulation for essential tremor: a systematic review. Movement Disorders 2010;25(11):1550. - PubMed
Follmann 1992
    1. Follmann D, Elliott P, Suh I, Cutler J. Variance imputation for overviews of clinical trials with continuous response. Journal of Clinical Epidemiology 1992;45(7):769-73. - PubMed
Foncke 2006
    1. Foncke EM, Schuurman PR, Speelman JD. Suicide after deep brain stimulation of the internal globus pallidus for dystonia. Neurology 2006;66(1):142-3. - PubMed
Furukawa 2006
    1. Furukawa TA, Barbui C, Cipriani A, Brambilla P, Watanabe N. Imputing missing standard deviations in meta-analyses can provide accurate results. Journal of Clinical Epidemiology 2006;59(1):7-10. - PubMed
GRADEpro GDT [Computer program]
    1. McMaster University (developed by Evidence Prime) GRADEpro GDT. Version accessed June 2018. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015. Available at gradepro.org.
Gross 2013
    1. Gross RE, McDougal ME. Technological advances in the surgical treatment of movement disorders. Current Neurology and Neuroscience Reports 2013;13(8):371. - PMC - PubMed
Guyatt 2011
    1. Guyatt GH, Oxman AD, Kunz R, Brozek J, Alonso-Coello P, Rind D, et al. GRADE guidelines 6. Rating the quality of evidence – imprecision. Journal of Clinical Epidemiology 2011;64(12):1283-93. - PubMed
Hallett 1998
    1. Hallett M. The neurophysiology of dystonia. Archives of Neurology 1998;55(5):601-3. - PubMed
Hashimoto 2003
    1. Hashimoto T, Elder CM, Okun MS, Patrick SK, Vitek JL. Stimulation of the subthalamic nucleus changes the firing pattern of pallidal neurons. The Journal of Neuroscience 2003;23(5):1916-23. - PMC - PubMed
Hedges 1985
    1. Hedges LV, Olkin I. Statistical Methods for Meta-Analysis. Academic Press, 1985.
Higgins 2003
    1. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-60. - PMC - PubMed
Higgins 2011a
    1. Higgins JPT, Altman DG, Sterne JAC, editor(s). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Higgins 2011b
    1. Higgins JPT, Deeks JJ, editor(s). Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Higgins 2011c
    1. Higgins JPT, Deeks JJ, Altman DG, editor(s). Chapter 16: Special topics in statistics. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Imberger 2016
    1. Imberger G, Thorlund K, Gluud C, Wetterslev J. False-positive findings in Cochrane meta-analyses with and without application of trial sequential analysis: an empirical review. BMJ Open 2016;6(8):e011890. - PMC - PubMed
Jakobsen 2014
    1. Jakobsen JC, Wetterslev J, Winkel P, Lange T, Gluud C. Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods. BMC Medical Research Methodology 2014;14(1):120. - PMC - PubMed
Jinnah 2014
    1. Jinnah HA, Albanese A. The new classification system for the dystonias: Why was it needed and how was it developed? Movement Disorders Clinical Practice 2014;1(4):280-4. - PMC - PubMed
Liberati 2009
    1. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Medicine 2009;6(7):e1000100. - PMC - PubMed
Limousin‐Dowsey 1999
    1. Limousin-Dowsey P, Pollak P, Van Blercom N, Krack P, Benazzouz A, Benabid A. Thalamic, subthalamic nucleus and internal pallidum stimulation in Parkinson's disease. Journal of Neurology 1999;246(Suppl 2):1142-5. - PubMed
Marques 2016
    1. Marques RE, Duarte GS, Rodrigues FB, Castelão M, Ferreira J, Sampaio C, et al. Botulinum toxin type B for cervical dystonia. Cochrane Database of Systematic Reviews 2016, Issue 5. Art. No: CD004315. [DOI: 10.1002/14651858.CD004315.pub3] - DOI - PMC - PubMed
Montuno 2013
    1. Montuno MA, Kohner AB, Foote KD, Okun MS. An algorithm for management of deep brain stimulation battery replacements: devising a web-based battery estimator and clinical symptom approach. Neuromodulation 2013;16(2):147-53. - PubMed
Moro 2017
    1. Moro E, LeReun C, Krauss JK, Albanese A, Lin J-P, Walleser Autiero S, et al. Efficacy of pallidal stimulation in isolated dystonia: a systematic review and meta-analysis. European Journal of Neurology 2017;24:552-60. - PMC - PubMed
O'Brien 1979
    1. O’Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics 1979;35(3):549-56. - PubMed
Peters 2006
    1. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Comparison of two methods to detect publication bias in meta-analysis. JAMA 2006;295(6):676-80. - PubMed
Phukan 2011
    1. Phukan J, Albanese A, Gassner T, Warner T. Primary dystonia and dystonia-plus syndromes: clinical characteristics, diagnosis, and pathogenesis. Lancet Neurology 2011;10(12):1074-85. - PubMed
Pirio Richardson 2017
    1. Pirio Richardson S, Wegele AR, Skipper B, Deligtisch A, Jinnah HA. Dystonia treatment: patterns of medication use in an international cohort. Neurology 2017;88(6):543-50. - PMC - PubMed
R 2017 [Computer program]
    1. R Foundation for Statistical Computing R: A language and environment for statistical computing. Version 3.4.2. Vienna, Austria: R Foundation for Statistical Computing, 2017. Available at www.R-project.org.
Review Manager 2014 [Computer program]
    1. Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Rubin 1991
    1. Rubin DB, Schenker N. Multiple imputation in health-care databases: an overview and some applications. Statistics in Medicine 1991;10:585–98. - PubMed
Simpson 2016
    1. Simpson DM, Hallett M, Ashman EJ, Comella CL, Green MW, Gronseth GS, et al. Practice guideline update summary. Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache. Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 2016;86(19):1818-26. - PMC - PubMed
Smeeth 1999
    1. Smeeth L, Haines A, Ebrahim S. Numbers needed to treat derived from meta-analysis – sometimes informative, usually misleading. BMJ 1999;318(7197):1548-51. - PMC - PubMed
Stata 2015 [Computer program]
    1. Stata. Version 14. College Station, TX, USA: StataCorp, 2015. Available at www.stata.com.
Steeves 2012
    1. Steeves TD, Day L, Dykeman J, Jette N, Pringsheim T. The prevalence of primary dystonia: a systematic review and meta‐analysis. Movement Disorders 2012;27(14):1789-96. - PubMed
Sterne 2001
    1. Sterne JA, Egger M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. Journal of Clinical Epidemiology 2001;54(10):1046-55. - PubMed
Sterne 2011
    1. Sterne JAC, Egger M, Moher D, editor(s). Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Tarsy 2006
    1. Tarsy D, Simon DK. Dystonia. The New England Journal of Medicine 2006;355(8):818-29. - PubMed
Thorlund 2011
    1. Thorlund K, Engstrøm J, Wetterslev J, Brok J, Imberger G, Gluud C. User manual for trial sequential analysis (TSA). www.ctu.dk/tsa/files/tsa_manual.pdf 2011;(accessed June 2017).
Toda 2016
    1. Toda H, Saiki H, Nishida N, Iwasaki K. Update on deep brain stimulation for dyskinesia and dystonia: a literature review. Neurologia Medico-chirurgica 2016;56(5):236-48. - PMC - PubMed
TSA 2011 [Computer program]
    1. CTU Copenhagen Trial Unit, Centre for Clinical Intervention Research Trial Sequential Analysis (TSA). Version 0.9 Beta. Copenhagen: CTU Copenhagen Trial Unit, Centre for Clinical Intervention Research, 2011. Available from www.ctu.dk/tsa/.
Waln 2014
    1. Waln O, Jimenez-Shahed J. Rechargeable deep brain stimulation implantable pulse generators in movement disorders: patient satisfaction and conversion parameters. Neuromodulation 2014;17(5):425-30. - PubMed
Wetterslev 2008
    1. Wetterslev J, Thorlund K, Brok J, Gluud C. Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. Journal of Clinical Epidemiology 2008;61(1):64-75. - PubMed
Wetterslev 2009
    1. Wetterslev J, Thorlund K, Brok J, Gluud C. Estimating required information size by quantifying diversity in random-effects model meta-analyses. BMC Medical Research Methodology 2009;9:86. - PMC - PubMed
Wiebe 2006
    1. Wiebe N, Vandermeer B, Platt RW, Klassen TP, Moher D, Barrowman NJ. A systematic review identifies a lack of standardization in methods for handling missing variance data. Journal of Clinical Epidemiology 2006;59(4):342-53. - PubMed

LinkOut - more resources